GL1X · GenesisL1 explorer

MolNFT v1 · #118603 · protein

Crystal structure of CHREBP:14-3-3 complex bound with AMP

5F74 · 14-3-3 protein BETA/ALPHA: “Crystal structure of CHREBP:14-3-3 complex bound with AMP”. X-ray diffraction, 1 ligand (AMP), 2 pockets (best druggability 0.66). MolNFT v1 #118603 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5F74
Type
protein
Length
249 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
14-3-3 protein BETA/ALPHA; Carbohydrate-responsive element-binding protein
UniProt
Q9CQV8, Q8VIP2
Ligands
AMP
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 83% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A14-3-3 protein BETA/ALPHAprotein22983% helix, 0% strandQ9CQV8
BCarbohydrate-responsive element-binding proteinprotein2085% helix, 0% strandQ8VIP2

Ligands and binding sites

  • AMP · Adenosine monophosphate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15320.660.7737AMP
2940.450.7916empty

Interfaces

1 interface between chains.

  • A–B · 873 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 5F74 · Crystal structure of ChREBP:14-3-3 complex bound with AMP · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9CQV8 · AlphaFold monomer V2.0 prediction for 14-3-3 protein BETA/ALPHA (Q9CQV8) · a predicted model of the same protein · chain A against A, TM-score 0.99
  • Q8VIP2 · AlphaFold monomer V2.0 prediction for carbohydrate-responsive element-binding protein… · a predicted model of the same protein · chain B against A, TM-score 0.53

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.